Your browser doesn't support javascript.
loading
Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia.
Darabi, Maryam; Lhomme, Marie; Ponnaiah, Maharajah; Pucic-Bakovic, Maja; Guillas, Isabelle; Frisdal, Eric; Bittar, Randa; Croyal, Mikaël; Matheron-Duriez, Lucrèce; Poupel, Lucie; Bonnefont-Rousselot, Dominique; Frere, Corinne; Varret, Mathilde; Krempf, Michel; Cariou, Bertrand; Lauc, Gordan; Guerin, Maryse; Carrie, Alain; Bruckert, Eric; Giral, Philippe; Le Goff, Wilfried; Kontush, Anatol.
Affiliation
  • Darabi M; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France; LPS-BioSciences (Current affiliation of Dr Darabi), Université de Paris-Saclay, Orsay, France.
  • Lhomme M; ICAN Analytics (Dr Lhomme), Lipidomics Core, Foundation for Innovation in Cardiometabolism and Nutrition (IHU-ICAN, ANR-10-IAHU-05), Paris, France.
  • Ponnaiah M; ICAN I/O (Dr Ponnaiah), Foundation for Innovation in Cardiometabolism and Nutrition (IHU-ICAN, ANR-10-IAHU-05), Paris, France.
  • Pucic-Bakovic M; Genos Glycoscience Research Laboratory (Drs Pucic-Bakovic and Lauc), Borongajska cesta 83H, HR-10 000 Zagreb, Croatia.
  • Guillas I; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France.
  • Frisdal E; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France.
  • Bittar R; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France; Department of Metabolic Biochemistry (Drs Bittar and Bonnefont-Rousselot), Pitié-Salpêtrière-Charles
  • Croyal M; Université de Nantes (Drs Cariou et Croyal), CHU Nantes, CNRS, INSERM, l'Institut du Thorax, F-44000 Nantes, France; Université de Nantes (Dr Croyal), CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, CNRS UMS 3556, F-44000 Nantes, France; CRNH-Ouest Mass Spectrometry Core Facility (Drs Croyal an
  • Matheron-Duriez L; Platform MS3U (Dr Matheron), Institut de Biologie Paris Seine FR 3631, Sorbonne Université, Paris, France.
  • Poupel L; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France.
  • Bonnefont-Rousselot D; Department of Metabolic Biochemistry (Drs Bittar and Bonnefont-Rousselot), Pitié-Salpêtrière-Charles Foix Hospital, AP-HP, Paris, France; Université de Paris (Dr Bonnefont-Rousselot), CNRS, INSERM, UTCBS, F-75006 Paris, France.
  • Frere C; Department of Haematology (Dr Frere), Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Sorbonne Université, Paris, France.
  • Varret M; Paris University and Sorbonne Paris Nord University (Dr Varret), National Institute for Health and Medical Research (INSERM, LVTS), F-75018 Paris, France.
  • Krempf M; CRNH-Ouest Mass Spectrometry Core Facility (Drs Croyal and Krempf), F-44000 Nantes, France; Clinique Bretéché (Dr Krempf), Groupe Elsan, Nantes, France.
  • Cariou B; Université de Nantes (Drs Cariou et Croyal), CHU Nantes, CNRS, INSERM, l'Institut du Thorax, F-44000 Nantes, France.
  • Lauc G; Genos Glycoscience Research Laboratory (Drs Pucic-Bakovic and Lauc), Borongajska cesta 83H, HR-10 000 Zagreb, Croatia.
  • Guerin M; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France.
  • Carrie A; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France.
  • Bruckert E; Endocrinologie Métabolisme et Prévention Cardiovasculaire (Drs Bruckert and Giral), Institut E3M et IHU Cardiométabolique (ICAN), Hôpital Pitié Salpêtrière, Paris, France.
  • Giral P; Endocrinologie Métabolisme et Prévention Cardiovasculaire (Drs Bruckert and Giral), Institut E3M et IHU Cardiométabolique (ICAN), Hôpital Pitié Salpêtrière, Paris, France.
  • Le Goff W; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France.
  • Kontush A; Sorbonne Université, INSERM (Drs Darabi, Guillas, Frisdal, Poupel, Carrie,Bittar, Guerin, Le Goff, and Kontush), Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, F-75013 Paris, France. Electronic address: anatol.kontush@sorbonne-universite.fr.
J Clin Lipidol ; 17(5): 643-658, 2023.
Article in En | MEDLINE | ID: mdl-37550151
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proprotein Convertase 9 / Hyperlipoproteinemia Type II Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Clin Lipidol Journal subject: BIOQUIMICA / METABOLISMO Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proprotein Convertase 9 / Hyperlipoproteinemia Type II Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Clin Lipidol Journal subject: BIOQUIMICA / METABOLISMO Year: 2023 Document type: Article Affiliation country: